A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

N-Nitroso Zongertinib - Request Quote

Picture of N-Nitroso Zongertinib

N-Nitroso Zongertinib

SZ CAT No:SZ-Z034007
CAS No
NA
Mol.F.
C22H17ClN8O2S
Mol.Wt.
492.9
Inv. Status
Synthesis on demand

Chemical Name :

Shipping Temperature :

HSN Code :

Country of Origin :

Smiles :

Usage Note:

N-Nitroso Zongertinib is chemically N-(2-chloro-3-methyl-4-((1-methyl-1H-benzo[d]imidazol-5-yl)oxy)phenyl)-N-(6-(methylthio)pyrimido[5,4-d]pyrimidin-4-yl)nitrous amide. N-Nitroso Zongertinib is supplied with detailed characterization data compliant with regulatory guideline. N-Nitroso Zongertinib can be used for the analytical method development, method validation (AMV), Quality Controlled (QC) application for Abbreviated New Drug Application (ANDA) or during commercial production of Zongertinib.

The product can be used as reference standards and further traceability against pharmacopeial standards (USP or EP) can be provided based on feasibility. SynZeal products are for analytical purpose only and not for human use.

Applications & Regulatory Use Cases

buy high quality N-Nitroso Zongertinib

Purchase N-Nitroso Zongertinib

N-Nitroso Zongertinib suppliers

N-Nitroso Zongertinib manufacturers

N-Nitroso Zongertinib price

Order N-Nitroso Zongertinib

Enquire N-Nitroso Zongertinib

N-Nitroso Zongertinib cost

N-Nitroso Zongertinib Supplier

N-Nitroso Zongertinib Distributor

N-Nitroso Zongertinib for Method Validation

Zongertinib Reference Standard

N-Nitroso Zongertinib for ANDA Filing

N-Nitroso Zongertinib for Forced Degradation Studies

N-Nitroso Zongertinib Identification Standards

N-Nitroso Zongertinib for DMF Filing

ℹ️

Disclaimer

SynZeal product information given on this website is as per the existing understanding while publishing the details on website. The customer is responsible for assessing the accuracy of the information at the time of actual purchase.

SynZeal will update these details as per new developments or findings in product specifications without further notice.